Specification :

Molecular formula:ingredient N-[5 - [N-methyl-N-(2 - methyl -4 - oxo -3,4 - dihydro-quinazoline -6 --methyl) amino] -2 - thiophene carbonyl]-L-glutamate

Indication: advanced colorectal cancer for first-line treatment.
Adverse reactions :after intravenous infusion of common side effects of the chemicals toxic to the blood, including bone marrow suppression, neutropenia, thrombocytopenia, such as, gastrointestinal side effects are nausea, vomiting, diarrhea, headache, insomnia, skin rashes and other phenomena, generally well tolerated in patients, a low incidence of side effects.
No interaction with the goods warfarin, non-steroidal anti-inflammatory drug interactions, it is recommended this product with calcium folinate, folic acid and vitamin combination preparation in order to avoid interaction with other cells Poison safety of combination therapy has not been established.
Usage consumption:recommended dose for each of 3 mg / ¡, 25 to 250 ml 0.9% saline or 5% glucose intravenous drip diluted more than 15 min, repeated every 3 weeks administration of 1.
[Drug overdose] excessive use of drugs have serious blood toxicity, such as bone marrow suppression and gastrointestinal toxicity, should avoid the use of excessive or prescribed, drug overdose may be given every 6 h calcium folinate 25 mg /m2.
Email:skyworth_pharma@126.com or skyworth_pharma@yahoo.com